Proteomic  	Proteomic  	 JJ	B-NP
profiling  	profiling  	 NN	I-NP
in  	in  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
To  	To  	 TO	O
describe  	describe  	 VB	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
proteomic  	proteomic  	 JJ	B-NP
profiling  	profiling  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
diagnosis  	diagnosis  	 NN	O
and  	and  	 CC	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer 	cancer 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
report  	report  	 VBP	O
a  	a  	 DT	O
thorough  	thorough  	 JJ	O
review  	review  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
literature 	literature 	 NN	O
,  	,  	 ,	O
ongoing  	ongoing  	 JJ	O
trials 	trials 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
our  	our  	 PRP$	O
group 	group 	 NN	O
's  	's  	 POS	O
experience  	experience  	 NN	O
with  	with  	 IN	O
proteomic  	proteomic  	 JJ	B-NP
profiling  	profiling  	 NN	I-NP
for  	for  	 IN	O
early  	early  	 JJ	O
detection 	detection 	 NN	O
,  	,  	 ,	O
recurrence 	recurrence 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer 	cancer 	 NN	I-NP
.  	.  	 .	O
Ovarian  	Ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
remains  	remains  	 VBZ	O
the  	the  	 DT	O
deadliest  	deadliest  	 JJS	O
gynecologic  	gynecologic  	 JJ	B-NP
malignancy  	malignancy  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
western  	western  	 JJ	O
world  	world  	 NN	O
and  	and  	 CC	O
is  	is  	 VBZ	O
most  	most  	 RBS	O
often  	often  	 RB	O
diagnosed  	diagnosed  	 VBN	O
at  	at  	 IN	O
a  	a  	 DT	O
rarely  	rarely  	 RB	O
curable  	curable  	 JJ	O
late  	late  	 JJ	O
stage 	stage 	 NN	O
.  	.  	 .	O
Novel  	Novel  	 NN	O
applications  	applications  	 NNS	O
of  	of  	 IN	O
proteomic  	proteomic  	 JJ	B-NP
techniques 	techniques 	 NNS	I-NP
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
mass  	mass  	 JJ	B-NP
spectrometry 	spectrometry 	 NN	I-NP
,  	,  	 ,	O
show  	show  	 NN	B-NP
promise  	promise  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
quest  	quest  	 NN	O
for  	for  	 IN	O
reliable  	reliable  	 JJ	O
multimodality  	multimodality  	 JJ	B-NP
screening  	screening  	 NN	I-NP
programs  	programs  	 NNS	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
early  	early  	 JJ	O
detection  	detection  	 NN	O
of  	of  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer 	cancer 	 NN	I-NP
.  	.  	 .	O
Proteomic  	Proteomic  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
of  	of  	 IN	O
tissue  	tissue  	 NN	O
samples  	samples  	 NNS	O
has  	has  	 VBZ	O
underscored  	underscored  	 VBN	O
the  	the  	 DT	O
heterogeneity  	heterogeneity  	 NN	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
disease  	disease  	 NN	B-NP
process 	process 	 NN	I-NP
.  	.  	 .	O
Development  	Development  	 NN	O
of  	of  	 IN	O
validated  	validated  	 JJ	O
assays  	assays  	 NN	O
that  	that  	 IN	O
survey  	survey  	 NN	O
the  	the  	 DT	O
genetic  	genetic  	 JJ	B-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
proteomic  	proteomic  	 JJ	B-NP
makeup  	makeup  	 NN	I-NP
of  	of  	 IN	O
an  	an  	 DT	O
individual  	individual  	 JJ	B-NP
tumor  	tumor  	 NN	I-NP
will  	will  	 MD	O
add  	add  	 VB	O
greatly  	greatly  	 RB	O
to  	to  	 TO	O
the  	the  	 DT	O
histological  	histological  	 JJ	B-NP
classification  	classification  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
tumor  	tumor  	 NN	I-NP
and  	and  	 CC	O
may  	may  	 MD	O
lead  	lead  	 VB	O
to  	to  	 TO	O
different  	different  	 JJ	O
treatment  	treatment  	 NN	O
approaches  	approaches  	 VBZ	O
tailored  	tailored  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
unique  	unique  	 JJ	O
expression  	expression  	 NN	B-NP
pattern  	pattern  	 NN	I-NP
of  	of  	 IN	O
each  	each  	 DT	O
individual  	individual  	 JJ	B-NP
patient 	patient 	 NN	I-NP
.  	.  	 .	O
As  	As  	 IN	O
novel  	novel  	 NN	O
agents  	agents  	 NNS	O
that  	that  	 IN	O
disrupt  	disrupt  	 JJ	O
signal  	signal  	 NN	B-NP
propagation  	propagation  	 NNS	I-NP
develop 	develop 	 VBP	O
,  	,  	 ,	O
proteomic  	proteomic  	 JJ	B-NP
profiling  	profiling  	 NN	I-NP
by  	by  	 IN	O
reverse-phase  	reverse-phase  	 JJ	B-NP
protein  	protein  	 NN	I-NP
arrays  	arrays  	 NNS	I-NP
can  	can  	 MD	O
characterize  	characterize  	 VB	O
the  	the  	 DT	O
in-tumor  	in-tumor  	 JJ	B-NP
efficacy  	efficacy  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
agent  	agent  	 NN	I-NP
by  	by  	 IN	O
quantification  	quantification  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
expression  	expression  	 NN	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	O
activated  	activated  	 JJ	O
proteins 	proteins 	 NNS	O
.  	.  	 .	O
Together 	Together 	 RB	O
,  	,  	 ,	O
better  	better  	 JJR	O
understanding  	understanding  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
potential  	potential  	 JJ	B-NP
diagnostic  	diagnostic  	 JJ	I-NP
and  	and  	 CC	O
therapeutic  	therapeutic  	 JJ	B-NP
targets  	targets  	 NNS	I-NP
followed  	followed  	 VBN	O
with  	with  	 IN	O
proof-of-target  	proof-of-target  	 JJ	B-NP
effect  	effect  	 NN	I-NP
will  	will  	 MD	O
lead  	lead  	 VB	O
to  	to  	 TO	O
rational  	rational  	 JJ	B-NP
combinations  	combinations  	 NNS	I-NP
of  	of  	 IN	O
novel  	novel  	 NN	O
therapy  	therapy  	 NN	O
and  	and  	 CC	O
improve  	improve  	 VB	O
individual  	individual  	 JJ	B-NP
ovarian  	ovarian  	 JJ	I-NP
cancer  	cancer  	 NN	I-NP
patient  	patient  	 NN	I-NP
outcome 	outcome 	 NN	I-NP
.  	.  	 .	O
